7 / 38
BOLERO-2: Final Analysis of Progression-Free Survival
by (A) Local and (B) Central Assessment
HR, hazard ratio; CI, confidence interval; EVE, everolimus; EXE, exemestane; PBO, placebo; mo, months.
Yardley D, et al.
Adv Ther.
2013;30(10):870-884.
A.
B.